Some solid tumors, including uveal melanoma [31–33], breast cancer [34, 35], and pancreatic cancer [36], have relatively low frequencies of SF3B1 mutations compared with hematological malignancies. This evidence concerns the gene SF3B1 and breast carcinoma.